ES2658115A1 - Compositions of cisatracurium and beta-cyclodextrin derivatives. (Machine-translation by Google Translate, not legally binding) - Google Patents
Compositions of cisatracurium and beta-cyclodextrin derivatives. (Machine-translation by Google Translate, not legally binding) Download PDFInfo
- Publication number
- ES2658115A1 ES2658115A1 ES201730681A ES201730681A ES2658115A1 ES 2658115 A1 ES2658115 A1 ES 2658115A1 ES 201730681 A ES201730681 A ES 201730681A ES 201730681 A ES201730681 A ES 201730681A ES 2658115 A1 ES2658115 A1 ES 2658115A1
- Authority
- ES
- Spain
- Prior art keywords
- cisatracurium
- translation
- machine
- legally binding
- google translate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- YXSLJKQTIDHPOT-LJCJQEJUSA-N cisatracurium Chemical group C1=C(OC)C(OC)=CC=C1C[C@H]1[N@+](CCC(=O)OCCCCCOC(=O)CC[N@+]2(C)[C@@H](C3=CC(OC)=C(OC)C=C3CC2)CC=2C=C(OC)C(OC)=CC=2)(C)CCC2=CC(OC)=C(OC)C=C21 YXSLJKQTIDHPOT-LJCJQEJUSA-N 0.000 title abstract 2
- 229960000358 cisatracurium Drugs 0.000 title abstract 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 239000001116 FEMA 4028 Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 1
- 229960004853 betadex Drugs 0.000 abstract 1
- 239000007853 buffer solution Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical aqueous solution comprising cisatracurium, or a pharmaceutically acceptable salt thereof, a derivative of sulfoalkylether- β -cyclodextrin and an acid buffer solution. (Machine-translation by Google Translate, not legally binding)
Description
Claims (1)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1608191.1A GB201608191D0 (en) | 2016-05-10 | 2016-05-10 | Cisatracurium and beta-cyclodextrin derivative compositions |
| GB16081911 | 2016-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2658115A1 true ES2658115A1 (en) | 2018-03-08 |
Family
ID=56297464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES201730681A Withdrawn ES2658115A1 (en) | 2016-05-10 | 2017-05-10 | Compositions of cisatracurium and beta-cyclodextrin derivatives. (Machine-translation by Google Translate, not legally binding) |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2658115A1 (en) |
| GB (1) | GB201608191D0 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065142A1 (en) * | 2006-11-29 | 2008-06-05 | N.V. Organon | Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
| WO2013189800A1 (en) * | 2012-06-22 | 2013-12-27 | Farmhispania S.A. | Cisatracurium and beta-cyclodextrin derivative compositions |
-
2016
- 2016-05-10 GB GBGB1608191.1A patent/GB201608191D0/en not_active Ceased
-
2017
- 2017-05-10 ES ES201730681A patent/ES2658115A1/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008065142A1 (en) * | 2006-11-29 | 2008-06-05 | N.V. Organon | Stabilized solution of rocuronium comprising a sulfoalkyl-ether-beta-cyclodextrin derivative |
| WO2013189800A1 (en) * | 2012-06-22 | 2013-12-27 | Farmhispania S.A. | Cisatracurium and beta-cyclodextrin derivative compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| GB201608191D0 (en) | 2016-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124011T1 (en) | GLYCOPEPTIDE COMPOSITIONS | |
| MX392213B (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING GLYCOPYRROLATE SALTS AND 1,1-DIFLUOROETHANE. | |
| MX380810B (en) | PROBES FOR IMAGING THE HUNTINGTIN PROTEIN. | |
| EP3684334C0 (en) | PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS MIXTURES OF WATER-MISCIBLE, PHARMACEUTICALLY ACCEPTABLE SOLVENTS | |
| MX391812B (en) | STEROID-DERIVED FXR AGONIST. | |
| EA201892007A1 (en) | 3-DESOXY DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ON ITS BASIS | |
| MX381487B (en) | CERTAIN PROTEIN KINASE INHIBITORS. | |
| SA521422143B1 (en) | 15-PGDH inhibitor | |
| CY1124251T1 (en) | CARBOXAMIDE DERIVATIVES | |
| BR112015030399B8 (en) | HETEROCYCLIC DERIVATIVES, USE OF SUCH DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DISEASES ASSOCIATED WITH STAT3 PROTEIN ACTIVATION | |
| AR098168A1 (en) | STABLE FORMULATION OF GLULISINE INSULIN | |
| MX383577B (en) | SUBSTITUTED GUANIDINE DERIVATIVES. | |
| LT3866767T (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING AN AMINOPYRIMIDINE DERIVATIVE OR ITS SALT | |
| EA202090368A1 (en) | LYSOPHOSPHATID ACID RECEPTOR COMPOUNDS 1 (LPAR1) | |
| MX382156B (en) | PROBES FOR IMAGING HUNTINGTIN PROTEIN. | |
| CY1123576T1 (en) | FUSED THIOPHENE DERIVATIVES USEFUL AS NAPI-IIB INHIBITORS | |
| MX387725B (en) | PHARMACEUTICAL COMPOSITION. | |
| EA201890532A1 (en) | NEW ANNELED BENZAMIDES | |
| DK3737470T3 (en) | 3-PHENYL-4-HEXYNIC ACID DERIVATIVES AS GPR40 AGONISTS | |
| CL2018001067A1 (en) | Pyranodipyridine compound. | |
| EA201891682A1 (en) | AZACYCLIC AMID DERIVATIVE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL APPLICATION | |
| BR112015021480A2 (en) | intrathecal hydromorphone solutions having improved stability | |
| BR112016013974A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF THE PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND | |
| BR112017024126B8 (en) | PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF | |
| MX2017008072A (en) | FORMULATIONS OF A PI3K / MTOR INHIBITOR FOR INTRAVENOUS ADMINISTRATION. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA2A | Application withdrawn |
Effective date: 20180628 |